Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 11/20 | 0.44 |
| ▸ | F2 | P00734 | 7/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 7/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.41 |
| ▸ | RHEB | Q15382 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30967836 | 1.00 | F10 (0.44) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL29237722 | 0.82 | F10 (0.56) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL30217325 | 0.82 | F10 (0.56) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL29237351 | 0.81 | F10 (0.46) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL30938228 | 0.81 | F10 (0.46) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL30285660 | 0.81 | F10 (0.46) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL29336712 | 0.81 | F10 (0.46) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL29336701 | 0.80 | F10 (0.47) | F10F2PRSS1PRSS2PRSS3 | |
| SCHEMBL29237564 | 0.79 | BRD4 (0.44) | RHEB | |
| SCHEMBL30967796 | 0.79 | BRD4 (0.44) | RHEB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201919-A | Indole compounds and methods of use | 健赞公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2024054840-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SIONNA THERAPEUTICS (US) | 2024-03-14 | — | — | WO | disclosed |